Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kristensen

Showing results (151-160 of 320) with videos related to

Pageof 32
Sort By:
Tissue Antigens|July 24, 2002
Establishment of a quantitative ELISA capable of determining peptide - MHC class I interactionC Sylvester-Hvid, N Kristensen, T Blicher, et al.
Genome Research|November 23, 2007
Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomicsXavier Roca, Andrew J Olson, Atmakuri R Rao, et al.
Molecular Oncology|April 27, 2024
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancerThomas Fleischer, Mads Haugland Haugen, Jørgen Ankill, et al.
Breast Cancer Research and Treatment|August 23, 2018
Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancerVahid Bemanian, John Christopher Noone, Torill Sauer, et al.
Molecular Oncology|August 13, 2019
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancerEvita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, et al.
Pharmacogenetics and Genomics|February 28, 2008
Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patientsRadka Vaclavikova, Silje H Nordgard, Grethe I G Alnaes, et al.
BMC Genomics|January 18, 2006
Multilocus analysis of SNP and metabolic data within a given pathwayVessela N Kristensen, Anya Tsalenko, Jurgen Geisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 InhibitionLeonard Schmiester, Fara Brasó-Maristany, Blanca González-Farré, et al.
BMC Cancer|October 8, 2013
Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumorsJovana Klajic, Thomas Fleischer, Emelyne Dejeux, et al.
Cancers|September 28, 2023
MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer PatientsTorgeir Mo, Siri Helene Bertelsen Brandal, Oliver Marcel Geier, et al.
Pageof 32

Showing results (151-160 of 320) with videos related to

Sort By:
Pageof 32
Tissue Antigens|July 24, 2002
Establishment of a quantitative ELISA capable of determining peptide - MHC class I interactionC Sylvester-Hvid, N Kristensen, T Blicher, et al.
Genome Research|November 23, 2007
Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomicsXavier Roca, Andrew J Olson, Atmakuri R Rao, et al.
Molecular Oncology|April 27, 2024
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancerThomas Fleischer, Mads Haugland Haugen, Jørgen Ankill, et al.
Breast Cancer Research and Treatment|August 23, 2018
Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancerVahid Bemanian, John Christopher Noone, Torill Sauer, et al.
Molecular Oncology|August 13, 2019
miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancerEvita Maria Lindholm, Miriam Ragle Aure, Mads Haugland Haugen, et al.
Pharmacogenetics and Genomics|February 28, 2008
Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patientsRadka Vaclavikova, Silje H Nordgard, Grethe I G Alnaes, et al.
BMC Genomics|January 18, 2006
Multilocus analysis of SNP and metabolic data within a given pathwayVessela N Kristensen, Anya Tsalenko, Jurgen Geisler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 InhibitionLeonard Schmiester, Fara Brasó-Maristany, Blanca González-Farré, et al.
BMC Cancer|October 8, 2013
Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumorsJovana Klajic, Thomas Fleischer, Emelyne Dejeux, et al.
Cancers|September 28, 2023
MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer PatientsTorgeir Mo, Siri Helene Bertelsen Brandal, Oliver Marcel Geier, et al.
Pageof 32